FDA’s FY 2026 Budget Request Lacks New Policy Proposals

The White House requested $6.8bn for the FDA, down 3.9% from the current funding level, but does not propose any legislative changes. In previous years, the agency used the budget process to seek statutory fixes specific to generic drugs and shortages.

Fingers on coins
The FDA is seeking a 3.9% cut in its budget for FY 2026. (Shutterstock)

More from Regulation

More from Wellness